FibroBiologics meets NASDAQ listing requirements

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. LVS
8. CSX
9. LRCX
10. MRK

Go back to FibroBiologics meets NASDAQ listing requirements

FibroBiologics Compliant with All Nasdaq Listing Requirements

April 20, 2026 4:01 PM EDT

HOUSTON, April 20, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (FibroBiologics), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that The Nasdaq Stock Market LLC (Nasdaq) has confirmed that the Company has demonstrated compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $2.5 million stockholders equity requirement and the $1.00 bid price requirement.

The Company has now successfully resolved its Nasdaq compliance issues but will remain... More